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extracted from fresh cells. The PCR products were cloned into the PGEM-T vector (Promega, Madison, WI). duplicate and all PCR runs were performed three times. Each sequence was quantified relative to a standard curve of its cognate cloned cDNA sequence.
Real-time PCR
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RESULTS
SR protein levels in neutrophils and PBMC
In order to identify candidate proteins for the GCR alternative splicing factors, we compared the complements of SR proteins in cell extracts from human neutrophils, which are rich in GCRβ, with extracts from PBMC, which have low levels of GCRβ. Western-blot analysis of cell extracts was performed on 20 µg of nuclear extracts from neutrophils and PBMC separated from six normal donors. Both freshly isolated neutrophils and PBMC expressed SR proteins ( Figure 1 ). The blots were developed using chemiluminescence, and the intensity of each band was measured using a flatbed scanner and NIH Image . In order to identify the specific SRp30 species present in human neutrophils, we utilized realtime PCR and specific Taqman probe sets for SRp30a, SRp30b, and SRp30c. Figure 2 shows that only mRNAs encoding SRp30a and SRp30c were present in the neutrophils. Levels of SRp30c mRNA were approximately 23-fold higher (p=0.03, t-test for paired samples) than levels of SRp30a. This suggests that SRp30c is probably the predominant SR protein present in human neutrophils.
SR protein levels in neutrophils stimulated with IL-8
We have previously demonstrated that IL-8 enhances GC insensitivity in neutrophils by increasing synthesis of GCRβ relative to GCRα (10) . Therefore, we performed Western analysis on extracts from neutrophils which had been treated with IL-8 compared to unstimulated neutrophils ( Figure 3A ). Freshly isolated neutrophils were treated with IL-8 or medium only for Figure 3B ). Therefore, conditions which result in increased GCRβ levels in neutrophils also result in increased levels of SRp30 proteins in neutrophils.
PLB-985 cell differentiation
In order to obtain functional evidence of the identity of the GCR alternative splicing factor, we initially attempted to specifically inhibit SRp30a and SRp30c expressions in neutrophils using antisense phosphorothioate oligonucleotides. However, due to the brief viability of these cells in culture we were unable to obtain reproducible results. Therefore, we employed a model of neutrophil-like differentiation using the PLB-985 cell line (25). Cells of this line are capable of granulocytic maturation to become neutrophil-like in the presence of inducing agents such as retinoic acid. After exposure to retinoic acid, the cells become neutrophil-like. Figure 4 illustrates the morphology of PLB-985 cells after five days of exposure to retinoic acid.
GCRα and GCRβ levels in PLB-985 cells before and after neutrophilic differentiation.
In order to measure the dynamics of GCR expression upon differentiation of PLB 985 cells, we performed Western-blot analysis of GCR from lysates of cells prior to and after five days of retinoic acid exposure. Figure 5 revealed that GCRα and GCRβ levels both increased upon exposure to retinoic acid relative to undifferentiated PLB-985 cells. However, densitometry revealed that GCRβ levels (5.2±2. 
SR protein levels in undifferentiated and differentiated PLB-985 cells
In order to examine our hypothesis that enhanced alternative splicing of GCR pre-mRNA is associated with enhanced expression of SR proteins in the 30 kDa range, we performed
Western analysis on cell extracts prior to and after five days of exposure to retinoic acid.
Densitometry of the film shown in Figure 6A shows that SRp30 levels significantly increased after differentiation relative to undifferentiated cells. Figure 6B shows the density units of targeting of SRp30c with a specific phosphorothioate antisense molecule resulted in a dramatic reduction in GCRβ production for approximately 24 hours after transfection, while GCRα production was stimulated (Figure 8 ). Therefore, SRp30c was necessary for alternative splicing of GCR pre-mRNA to generate mRNA encoding GCRβ. Since SRp30c represents the major alternative splicing factor present in neutrophils, we conclude that SRp30c is required for alternative splicing to generate GCRβ mRNA. Since GCRβ is intimately involved in GC insensitivity, and GCRβ is dependent on the presence of SRp30c, this SR protein may make an attractive target for therapeutic intervention. M3:00824 
